Analyst consensus rating
HCA Healthcare Analyst Rating: Buy
HCA is rated Buy by 21 analysts with a $451.48 target. As of 2026-08-20.
Direct answer
HCA Healthcare's consensus rating is Buy.
21 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $451.48.
Forecast evidence checked August 20, 2026.
Get free HCA Healthcare email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $406.27
- Average price target
- $451.48
- High price target
- $579.00
- Low price target
- $380.00
- Low target gap
- -6.5%
- Target upside
- +11.1%
- High target gap
- +42.5%
- Target range width
- 49%
- Consensus rating
- Buy
- Analysts
- 21
- Evidence date
- August 20, 2026
- Valid through
- August 27, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for HCA Healthcare?
HCA Healthcare has a verified Buy consensus. The same dataset has an average price target of $451.48.
How far are HCA Healthcare's low and high targets from the recorded price?
The low target implies -6.5%, while the high target implies +42.5%.
How many analysts are included in HCA Healthcare's consensus?
The verified consensus includes 21 analysts.
How is HCA Healthcare's target upside or downside calculated?
The average target of $451.48 is divided by the recorded price of $406.27, then one is subtracted to produce +11.1%. This does not guarantee a future return.
When was HCA Healthcare's analyst forecast verified?
The data was verified on 2026-08-20. The dataset is valid through 2026-08-27.